Actualités Entremed, Inc. (MM) - ENMDD | Actions NASDAQ

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

EntreMed Regains Compliance With NASDAQ Minimum Bid Price Rule

EntreMed Regains Compliance With NASDAQ Minimum Bid Price Rule PR Newswire ROCKVILLE, Md., July 20 ROCKVILLE, Md., July 20 /PRNewswire-FirstCall/...

- Prospectus filed pursuant to Rule 424(b)(5) (424B5)

Filed Pursuant to Rule 424(b)(5) Registration No. 333-167754 PROSPECTUS EntreMed, Inc. Up to 403,550 shares of...

EntreMed's ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models

EntreMed's ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models Study Results Published in British...

- Notice of Effectiveness (EFFECT)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESS Effective Date: July 12, 2010 Form: S-3...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Entremed, Inc. (MM) (ENMDD)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ENMDD Actualités

EntreMed Regains Compliance With NASDAQ Minimum Bid Price Rule

- Prospectus filed pursuant to Rule 424(b)(5) (424B5)

EntreMed's ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models

- Notice of Effectiveness (EFFECT)

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Entremed, Inc. (MM) (ENMDD) Actualités

Entremed, Inc. (MM) (ENMDD)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ENMDD Actualités

EntreMed Regains Compliance With NASDAQ Minimum Bid Price Rule

- Prospectus filed pursuant to Rule 424(b)(5) (424B5)

EntreMed's ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models

- Notice of Effectiveness (EFFECT)

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités